ERBB2 and triple-negative breast carcinoma: The most aggressive subtype is triple negative breast cancer (TNBC), which lacks expression of the hormone receptors estrogen (ER)- and progesterone (PR)- receptor as well as the human epidermal growth factor receptor 2 (HER2) [12,13,14].